EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Kiyohara MH, Dillard C, Tsui J, Kim SR, Lu J, Sachdev D, Goodglick L, Tong M, Torous VF, Aryasomayajula C, Wang W, Najafzadeh P, Gordon LK, Braun J, McDermott S, Wicha MS, Wadehra M.
Kiyohara MH, et al. Among authors: wang w.
Oncogene. 2017 Oct 19;36(42):5793-5807. doi: 10.1038/onc.2017.142. Epub 2017 Jun 12.
Oncogene. 2017.
PMID: 28604744
Free PMC article.